Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe?
about
Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac HypertrophyThe contribution of prostaglandins versus prostacyclin in ventricular remodeling during heart failureRegulation of genes in the arachidonic acid metabolic pathway by RNA processing and RNA-mediated mechanismsOff-pump coronary artery bypass surgery is associated with fewer gene expression changes in the human myocardium in comparison with on-pump surgery.Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2.MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?Mechanism of QSYQ on anti-apoptosis mediated by different subtypes of cyclooxygenase in AMI induced heart failure rats.Cox-2 Inhibition Protects against Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis via Akt-Dependent Enhancement of iNOS ExpressionArginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity.Pathophysiology of cyclooxygenases in cardiovascular homeostasis.Targeting inflammation: impact on atherothrombosis.Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium.Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis.Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction.Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction.Xanthine Oxidase Activation Modulates the Endothelial (Vascular) Dysfunction Related to HgCl2 Exposure Plus Myocardial Infarction in Rats.Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts.Cyclooxygenase-2-derived prostacyclin protective role on endotoxin-induced mouse cardiomyocyte mortality.Low-dose celecoxib improves coronary function after acute myocardial ischaemia in rabbits.Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose
P2860
Q26748618-D0A71FEB-33FD-464F-ABB8-8FC56F18513DQ26830372-89CBE7C3-92D8-4DD9-BA19-95C55F18385DQ26849624-6A36CBDA-7018-401A-85E4-8D063BBFC813Q33924883-4D7D15C6-F407-4470-9793-B9FA4BDA0363Q33937192-D4D7F28B-69DA-447E-B026-F0F24D285421Q33991447-3EE9D982-9ED5-43A4-9D3E-0077B0C904F5Q35893380-A6516785-322A-46A9-8D5B-329759B1FF4FQ36135119-4CFDD98A-A7C7-4250-812C-012356C32BF2Q37344982-99A0BFAE-0ED2-47FF-B927-955549B35E8DQ37391969-F58A7EEB-E4A8-4739-9148-D7D447E163E4Q37429815-3C08DCAF-D641-49EB-A2BB-0A5B035170C9Q37736991-FB9D939F-63B8-4279-998D-B9C04ABEC0E7Q38170328-7BA25368-7DA6-41DC-946E-BDB10B08851DQ39364291-683622A5-D8EC-4728-AABC-A404E55EA992Q41889468-6F9AFFA1-A7FF-44A9-95AC-8C6E15226E80Q42078106-E5CB322B-63AE-4392-BD39-0B660FCC0AE5Q43010441-506EF17A-3347-457F-A17B-414659BE91FBQ47037319-45E2EACF-6F83-4D8E-BD36-C43902EA485FQ48319963-51569C23-7BFF-45DE-9687-DBDDFA8D1ACDQ50040307-74EEE5F4-5CFB-41A0-AFD9-8D5458DB4970Q54539115-561C6C63-76F0-4491-91B0-DE7AB598C62EQ57493002-339A18EC-7299-4EE4-9D05-8985EA84417F
P2860
Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cyclo-oxygenase-2 (COX-2) expr ...... ial infarction: friend or foe?
@ast
Cyclo-oxygenase-2 (COX-2) expr ...... ial infarction: friend or foe?
@en
type
label
Cyclo-oxygenase-2 (COX-2) expr ...... ial infarction: friend or foe?
@ast
Cyclo-oxygenase-2 (COX-2) expr ...... ial infarction: friend or foe?
@en
prefLabel
Cyclo-oxygenase-2 (COX-2) expr ...... ial infarction: friend or foe?
@ast
Cyclo-oxygenase-2 (COX-2) expr ...... ial infarction: friend or foe?
@en
P2093
P2860
P356
P1433
P1476
Cyclo-oxygenase-2 (COX-2) expr ...... ial infarction: friend or foe?
@en
P2093
Biasucci LM
Biondi-Zoccai GG
P2860
P304
P356
10.1136/HRT.2003.010280
P407
P577
2004-04-01T00:00:00Z